Skip to main content
Erin Parry, MD, Oncology, Boston, MA

ErinMParryMDPhD

Oncology Boston, MA

Physician

Dr. Parry is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Parry's full profile

Already have an account?

  • Office

    Dana-Farber Cancer Institute
    450 Brookline Avenue
    Boston, MA 02215
    Phone+1 617-632-3000

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2016 - 2020
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2013 - 2016
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2013

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2016 - 2026
  • VT State Medical License
    VT State Medical License 2022 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Chronic Lymphocytic Leukemia (CLL) Transformed into Hodgkin Lymphoma (HL): Clinical Characteristics and Outcomes from a Large Multi-Center Collaboration 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Mapping Genetic Evolution from CLL to Richter’s Syndrome
    Mapping Genetic Evolution from CLL to Richter’s SyndromeJanuary 10th, 2023
  • Scientists Map Genetic Evolution of Chronic Lymphocytic Leukemia to Richter’s Syndrome
    Scientists Map Genetic Evolution of Chronic Lymphocytic Leukemia to Richter’s SyndromeDecember 11th, 2022
  • Advances in Malignant Lymphoma: Discoveries from Precursors to Progression
    Advances in Malignant Lymphoma: Discoveries from Precursors to ProgressionJune 20th, 2022
  • Join now to see all